Abstract
Inhalation injury is a major contributor to poor outcomes in burn patients, increasing the risk of respiratory complications, prolonged hospitalization, and mortality. This review summarizes current knowledge on the pathophysiology, diagnosis, and management of airway burns, based on clinical studies and guidelines. Injuries may be supraglottic, subglottic, or systemic, each leading to inflammation, airway obstruction, and impaired gas exchange. Carbon monoxide and cyanide toxicity further worsen systemic hypoxia. Diagnosis depends on clinical signs, imaging, and bronchoscopy, which remains the gold standard. Treatment involves airway stabilization, ventilatory support, inhaled therapies, and antidotes for toxic exposure. Prognosis is affected by burn extent, systemic response, and comorbidities such as substance abuse. Survivors often experience long-term pulmonary dysfunction, emphasizing the need for early, multidisciplinary intervention.
Keywords: inhalation injury, burns, smoke systemic poisoning, pulmonary dysfunction
INTRODUCTION
Inhalation injuries are a severe complication of burns, often accompanying extensive skin damage and significantly increasing morbidity and mortality. These injuries raise the risk of pulmonary complications [1], and even isolated airway burns can lead to long-term lung dysfunction [2]. While some studies suggest they do not affect immediate survival [3], overall, long-term survival is lower in affected patients [4]. Mortality correlates with total body surface area burned and patient age, which also increases the likelihood of airway injury [4]. Recognizing their severity, European and American guidelines classify suspected inhalation injuries as a criterion for referral to specialized burn centers [5]. Incidence figures vary with setting and diagnostic criteria, ranging from ≈10 % in U.S. registries [6], through 0.3–43 % in European studies [7], to 4.9–11.3 % in recent Chinese reports [8].
THE PATHOPHYSIOLOGY OF INHALATION TRAUMA
The pathophysiology and evolution of airway burns differ according to the injury site and the agent causing the injury. Thus, anatomically, inhalation injuries are divided into supraglottic, subglottic, and systemic poisoning. The most important aetiologic agents of airway injuries are heat, carbon monoxide poisoning, and cyanide.
Supraglottic burns
Although temperatures can reach up to 500°C in an enclosed space fire, the low heat capacity of air, efficient heat dissipation in the upper airway, and reflex glottic closure usually limit true thermal injury to the airway above the carina [9]. Burns at this level can cause massive edema of the tongue, epiglottis, and aryepiglottic folds, which will cause airway obstruction. This edema may develop rapidly during fluid resuscitation, so the respiratory status should be continuously monitored, and initial assessment is not sufficient [1]. Preventive intubation should be considered if history and clinical examination raise the suspicion of airway burns.
Subglottic burns
Subglottic burns are typically caused by inhaled chemical toxins from burning materials [9,10], as superheated air alone, except for steam, does not reach this level. The composition of smoke influences the severity of the resulting inflammation. Key pathophysiologic changes include mucosal hyperemia, bronchospasm, fibrin and mucus plug formation, desquamation, surfactant loss, and impaired mucociliary clearance [9]. These lead to alveolar collapse [11], reduced oxygenation, and increased susceptibility to infection [10]. Toxins trigger bronchial inflammation, edema, and obstruction by debris and secretions, causing ventilation-perfusion mismatch, systemic hypoxia, and heightened infection risk [10].
When the airways are obstructed in a particular region, the tidal volume redistributes to the unobstructed areas, which injures these regions through barotrauma and volumetric trauma, leading to acute respiratory distress syndrome (ARDS) and pneumothorax. All these changes affect the ventilation/oxygenation rate and result in right-left shunting [12]. ARDS represents the most severe lower-airway injury, resulting in noncardiogenic pulmonary oedema, CO2 retention, and marked hypoxaemia, often followed by multi-organ failure and death [13]. In a conscious, mechanically unventilated patient, tachypnoea and dyspnoea will be severe. According to the Berlin definition, ARDS is acute (onset within 7 days of a precipitating event), not fully explained by heart failure or fluid overload, requires positive end-expiratory pressure (PEEP) ≥ 5 cmH2O, and is classified by the ratio of arterial oxygen partial pressure to fraction of inspired oxygen (PaO2/FiO2): mild (200–300 mmHg), moderate (100–200 mmHg) and severe (< 100 mmHg) [14].
Systemic poisoning
Inhalation injuries cause systemic effects like hypoxemia, hypercapnia, acidosis, and widespread inflammation due to lung-derived mediators [1]. Additionally, toxic combustion products like carbon monoxide (CO) and cyanide contribute to systemic damage. CO, a colorless and odorless gas from incomplete combustion, is a leading cause of death at the scene in burn victims [1].
CO binds to haemoglobin (Hb) with approximately 200-fold greater affinity than oxygen (O2), causing the hemoglobin dissociation curve to shift to the left [9]. O2 supply to tissues is low due to compromised transport capacity and tissue-independent dissociation [10]. CO competitively inhibits the intracellular cytochrome enzyme system, particularly cytochrome P-450, resulting in the inability of cellular systems to utilize O2.
Hydrocyanic acid (hydrogen cyanide) also inhibits the cytochrome oxidase system and has a synergistic effect with carbon monoxide, producing tissue hypoxia, acidosis, and decreased oxygenation to the brain [1].
The biological half-life of carboxyhaemoglobin (COHb) is roughly 250 minutes when breathing room air, decreases to 40–60 minutes with 100 % O2, and can be further shortened by hyperbaric oxygen therapy. However, logistical challenges of monitoring and fluid resuscitation within a hyperbaric chamber often limit its use [15].
DIAGNOSIS OF INHALATION INJURY
Despite the particularly important role that inhalation injury plays in the outcome and survival of the burned patient, to date, there is no consensus on the diagnosis, staging, and prognosis of airway burns [16]. The anamnesis should be oriented to the identification of the burned material, the duration of exposure, the time elapsed since the burn occurred and how the smoke exposure was realized (confined or open fire/explosion, domestic or industrial accident), the time elapsed until the casualty was rescued or removed from the confined space [16,17].
Immediately after trauma, the signs and symptoms of airway burns may be minimal or non-existent. The progression, however, may be very rapid toward airway obstruction, which is life-threatening [18]. Suspicious signs of airway injury include facial burns, hoarse voice, burned vibrissae, sputum, and sooty oral cavity [17]. Facial edema, stridor, wheezing, dyspnea, and cyanosis are signs of advanced respiratory injury [4]. However, clinical examination alone can be misleading, and correlation with other investigations is necessary. One study showed that although 70% of patients with airway burns had facial burns, 70% of patients with facial burns did not also have significant lung injury [10].
Upon arrival at the emergency department, patients should undergo a standardized assessment including complete blood count, ionogram, arterial blood gas, creatinine, pulse oximetry, ECG, and heart-lung X-ray. Ideally, tests for carboxyhaemoglobin and cyanide in the blood will be performed [19]. In most cases, the initial radiograph and blood gas will be normal on admission or at most slightly altered, but they will undergo significant changes in evolution [4]. Computed tomography (CT) can detect distal airway injuries not visible on bronchoscopy; peribronchial ground-glass opacities may appear within three hours of inhalation trauma [20]. Supraglottic burns are diagnosed by direct visualization on clinical exam, and flexible laryngoscopy can assess vocal-cord injury when bronchoscopy is not immediately available [21]. Other possible imaging investigations that may confirm the diagnosis of airway burns would be technetium-99 or xenon computed tomography, but these investigations are very rare and expensive and are therefore not routinely used to diagnose airway injury [9].
However, history and clinical examination are subjective diagnostic tools compared to bronchoscopy [18]. Used in the diagnosis of airway burns since 1975 [22], flexible bronchoscopy (fibrobronchoscopy) is not yet widely available, but is widely used for rapid and reliable diagnosis of inhalational injuries [10]. Flexible bronchoscopy allows direct visualization of both the supraglottic floor and subglottic structures. Fibrobronchoscopy can identify and extract soot and other foreign bodies from the airways. It is also a useful tool for performing bronchoalveolar lavage, obtaining samples for bacteriologic culture, and initiating targeted antimicrobial therapy [23]. Flexible bronchoscopy is recommended for confirming cases of inhalational injuries in both high and low clinical suspicion patients, being an investigation with a low complication rate [24].
The severity of inhalational injury can be categorized, according to the Abbreviated Injury Score (AIS) scale (Table 1), which is usually correlated with: increased mortality [25] in some studies, but not always [26], a decrease in oxygenation [27], but also with inconsistent results [26] and an increase in the duration of mechanical ventilation [26]. However, not all studies could validate this conclusion [24].
Table 1.
Abbreviated Injury Score (AIS) system for fibrobronchoscopic staging of inhalation injury
| Grade | Class | Description |
|---|---|---|
| 0 | No lesions | Absence of sooty deposits, erythema, edema, bronchorrhea, or obstruction |
| 1 | Mild lesions | Small or patchy areas of erythema, sooty deposits in proximal or distal bronchi |
| 2 | Moderate lesions | Moderate erythema, sooty deposits, bronchorrhea, or bronchial obstruction |
| 3 | Severe lesions | Severe inflammation with friable mucosa, significant soot deposits, bronchorrhea, or obstruction |
| 4 | Massive injury | Mucosal desquamation, necrosis, and complete obliteration of the lumen |
Virtual bronchoscopy using computed tomography does not offer the benefits of fibrobronchoscopy and has not been established in current practice [24].
TREATMENT
As with all burns, therapeutic maneuvers should be started at the site of the trauma. The victim must be evacuated and decontaminated immediately. All clothing, as well as rings, watches, and jewelry, should be removed immediately, as they may be contaminated with toxins (hydrogen cyanide, for example), retain heat, or have a constrictive, tourniquet effect as edema develops [17]. A rapid primary survey following Advanced Life Support (ALS) principles (Airway, Breathing, Circulation) should identify and address any immediately life-threatening issues [16]. Securing the airway by intubation may be difficult at the trauma scene, depending on the skills of the first aid team and the existing airway edema [16]. It has been observed that the majority of intubations of burn patients in the United States (almost 75%) are performed in a pre-hospital setting by staff inexperienced in burn patient management [28]. For patients without obvious ventilatory disturbances at the trauma site, it may be prudent to delay intubation until arrival in the emergency department, where the necessary expertise and access to all the necessary tools for proper airway management are available. Given the possibility of multiple complications of intubating patients, the risk of intubation may outweigh the benefit [28]. In the case of victims who are short of breath, the decision to intubate becomes much more difficult. If transportation time to the hospital is short, mask ventilation with a humidified O2 reservoir may be a temporary solution. Obtaining and securing at least one peripheral venous pathway is mandatory, and fluid resuscitation should be started at the trauma site [17]. Subsequently, a second, more thorough assessment should be performed, and ideally, information should be obtained regarding medical history, allergies, and other concomitant injuries [16,17]. A general clinical examination, including a neurological examination [16,17], should also be performed.
Upper airway management
The risk of airway obstruction with loss of ventilation and oxygenation of the patient increases with time, as airway patency may decrease even with minimal airway burns, the individual response to the insult being highly variable [29]. Airway edema develops progressively, usually within the first 72 h, and is the result of a combination of local trauma, cutaneous burns, and fluid resuscitation [29]. Ideally, any stable patient with suspected airway burn should receive laryngoscopy, chest radiography, arterial blood gas analysis, and blood carbon monoxide determination in the emergency department in addition to the standard clinical examination [30]. If any of these investigations are pathologic, the airway should be secured by emergency orotracheal intubation [30]. Fibrobronchoscopy for evaluation of the lower airway should be performed only after securing the airway by intubation, ventilation control, surgical dressing of skin burns, and initial management of other coexisting injuries [30].
In the case of airway injury, airway edema will increase with fluid resuscitation; therefore, it is vital to secure the airway and control ventilation, even if the patient is conscious and not in respiratory failure at presentation. Although all patients with suspected airway burns are considered potential difficult intubation patients [30], if orotracheal intubation is delayed, it will become even more difficult because of severe upper airway edema that will develop after the start of fluid resuscitation [31].
Tracheostomy gives a long-lasting airway approach with increased patient comfort. A survey of 129 burn units facilities in the United States and Canada found that tracheostomy was performed, on average, two weeks after admission [32], despite an existing consensus for performing tracheostomy earlier than 2 weeks, with the general recommendation being in favor of tracheostomy for all patients requiring intubation longer than 7 days [33].
Lower airway management
Therapeutic measures considered for inhalation injuries in subglottic airways should ameliorate the main pathophysiologic changes of this condition: mucosal edema and hyperemia, expectoration of mucus and airway deposits, bronchospasm, and improvement of the ventilation/perfusion ratio. These measures must also not further injure the respiratory system through complications such as barotrauma [10].
Multiple experimental studies have shown that nebulization with agents that reduce the blood flow in the bronchial artery may be effective by reducing edema [34]. In theory, limiting fluid administration might also lessen pulmonary swelling, but clinical data show that under-resuscitation increases mortality, while excessive fluids raise the risk of ARDS in patients with large total surface-area burns [35]. Although the Parkland formula remains widely used (including in our centre), many units now employ computer-based algorithms to individualize fluid goals [36]. However, fluid administration should be titrated according to the diuresis value to avoid under- and overloading patients with fluids.
While traditionally used to diagnose lung infections, bronchoalveolar lavage is also effective for clearing pseudomembranes and airway debris, especially when performed repeatedly. Inhalation injury patients with pneumonia who underwent at least one fibrobronchoscopy had lower mortality, shorter ICU stays, and reduced hospitalization costs [37].
Airway clearance through the breakdown and expectoration of mucus and debris is central to treating subglottic burns. Due to the procoagulant effect of smoke inhalation, nebulized anticoagulants like heparin are beneficial [38]—they degrade fibrin deposits [39], prevent microvascular clotting [1], and have been shown to reduce mortality [1,9]. N-acetylcysteine, a mucolytic and antioxidant, promotes mucus clearance and is typically alternated with heparin every 4 hours [9]. Because it may trigger bronchospasm, it is administered with bronchodilators such as albuterol. This combined protocol has improved oxygenation, reduced ventilation days, and enhanced survival without increasing pneumonia or bleeding risk [40,41]. β2-agonists also help by relaxing airway smooth muscle, reducing inflammation, and supporting mucociliary function [42]. Epinephrine further improves oxygenation by reducing airway edema and bronchial constriction [43,44].
Bronchial hygiene is essential for clearing secretions, debris, and pathogens from the airways. It includes therapeutic coughing, deep breathing every 2 hours, chest physiotherapy (e.g., percussion, vibration), suctioning, and early mobilization [17]. Turning the patient every 4 hours [17] and using adjuncts like bronchoscopy, mucolytics, suctioning of secretions, and certain ventilation modes can further aid clearance [45].
Mechanical ventilation in burn patients is challenging due to hypercapnia, reduced chest compliance, and airway injury. It is indicated in cases of respiratory distress, hypoxemia (PaO2 <65 mmHg), hypercapnia (PaCO2 >50 mmHg), or a PaO2/FiO2 ratio <200 [46]. Inhalation injuries increase airway resistance and reduce lung compliance, raising the risk of barotrauma and ventilator-induced lung injury, which can progress to ARDS. Ventilation strategies should maintain oxygenation and airway patency while minimizing additional lung damage [46].
Management of systemic poisoning
In confined space fires with large smoke releases, not only do physical burns of the airways pose difficulties of care, but also poisoning from inhaled smoke inhalants such as carbon monoxide and cyanides. Treatment for these poisonings must be quick, as these substances have harmful systemic effects that can be fatal.
CO poisoning warrants emergency intervention when COHb levels exceed 10%. The amount of carboxyhaemoglobin in the blood can be measured by arterial blood gas measurement, thus quantifying the carbon monoxide level. The biological half-life of COHb depends on the inspired oxygen fraction: approximately 320 minutes on room air and 74 minutes with 100 % O2 [19]. Hyperbaric oxygen therapy (HBOT) can further shorten the COHb half-life by up to 20 minutes [19], although systematic reviews have not demonstrated clear superiority of HBOT over high-flow normobaric oxygen [47]. First-line treatment consists of 100 % O2 delivered via a high-flow non-rebreather mask or, if already intubated, through the endotracheal tube [48]. However, in patients in whom carboxyhaemoglobin levels remain elevated after oxygen administration, or whose mental status deteriorates, hyperbaric oxygen therapy is recommended, if the facility is available [49].
Smoke from combustion often also contains cyanides, especially from the combustion of plastics. Hydroxycobalamin, a natural derivative of vitamin B12, is the antidote of choice in Europe for the treatment of cyanide poisoning [36]. Intravenous administration of 5g of hydroxycobalamin over 15 min to patients with inhalational injuries has been correlated with a decrease in the number of pneumonias, a reduction in the number of days on mechanical ventilation, and a decrease in the duration that patients required intensive care [50]. Having minimal adverse effects, it can be administered empirically to all patients with suspected airway burns [50]. Another antidote used in cyanide poisoning is thiosulfate, but this treatment is less effective than hydroxycobalamin [17].
Antimicrobial therapy
Respiratory tract infections are the most common complications in individuals with burn injuries. Pneumonia development is common in burn patients, especially after 72 hours of hospitalization. Major risk factors include inhalation injury and endotracheal intubation [21,37].
Pneumonia associated with mechanical ventilation is a common complication of patients with inhalational injuries [51]. The initial antibiotic therapy is often empiric and later adjusted according to the antibiogram of positive cultures from bronchial aspirate or bronchoalveolar lavage fluid.
A decrease in the incidence of pneumonia was not observed in patients who received prophylactic antibiotic therapy, but one study observed a decrease in mortality among these patients [52]. However, prophylactic antibiotic therapy is associated with an increase in the number of antibiotic multidrug-resistant bacteria [53], which ultimately leads to increased mortality. Therefore, the recommended therapeutic strategy is obtaining serial cultures from bronchial secretions or bronchoalveolar lavage fluid for surveillance and initiating early targeted antimicrobial therapy in associated pneumonia [53].
Knowledge about airway microbiota after inhalation injury and its impact on prognosis is limited [54]. One study found that patients with early hypoxia showed increased levels of facultative anaerobes, such as Streptococcaceae, Enterobacteriaceae, and Staphylococcaceae, compared to those without hypoxia [55]. Additionally, mechanically ventilated patients show a progressive decline in lung microbiota diversity, which is linked to respiratory infections [56].
PROGNOSIS AND RECOVERY OF PATIENTS WITH INHALATION INJURY
Inhalation injury worsens burn outcomes, increasing overall mortality by up to 20 % compared to skin burns alone [57]. It raises the risk of respiratory failure, ARDS, and pneumonia. When pneumonia occurs alongside inhalation injury, mortality can reach 60% [9]. Even with a limited burn surface, airway burns significantly increase the risk of death [58]. Recent data have identified several predictors of poor outcome in inhalation-injured patients: larger total-burned surface area, development of ARDS, elevated lactate levels, leukocytosis, and derangements in liver and kidney function tests [59]. Severe inhalation injury was associated with decreased red blood cell counts, hemoglobin, platelets, and albumin. Leukocytosis >20.91×109/L indicated severity, lactic acid >9.6 mmol/L predicted ARDS, and hemoglobin <8.3 mg/dL predicted mortality [59]. Other studies have similarly linked elevated inflammatory markers, neutrophil infiltration [60], and low PaO2/FiO2 ratios [61] with increased mortality. Substance abuse, especially alcohol, also exacerbates risk: even patients with < 5 % total-body-surface-area burns who test positive for drugs or alcohol face higher rates of intubation, respiratory failure, longer intensive-care stays, and extended hospitalizations [62]. Recovery from airway burns is prolonged, and long-term complications are common. Survivors may have reduced lung capacity even decades later [63]. Pulmonary rehabilitation can aid recovery [64]. Dysphagia is also significantly more frequent, up to 16 times, in patients with airway burns compared to those with only skin burns [65]. A study of 830 burn patients found that inhalation injuries increased in-hospital mortality but had no impact on post-discharge mortality or readmission rates [66]. Another study reported similar long-term health outcomes, though return-to-work rates at 24 months were lower in those with inhalation injuries [67].
CONCLUSION
Inhalation injuries significantly worsen the prognosis of burn patients, increasing the risk of respiratory failure, systemic toxicity, and long-term complications. Early recognition, prompt airway management, and targeted therapies are essential to reduce mortality and improve outcomes. Despite advances in supportive care, the diagnosis and treatment of inhalation injuries remain challenging, highlighting the need for standardized protocols and continued research to optimize patient recovery.
Conflict of interest
The authors declare no conflict of interest.
Authorship
RAG, EMBD, AGB, IL, CSH were responsible for conceptualization. RAG, EMBD, AGB, CSH contributed to methodology; AGB, IL, CSH contributed to validation; RAG, EMBD, SG, CSH contributed to formal analysis. RAG, AGB, SG, CSD, RAC, CIC contributed to data curation. RAG, CIC was responsible for investigation. RAG, AF, SG, RAC, CSH contributed to resources. RAG, EMBD, CSD, AGB contributed to writing - review and editing. RAG, IL, CSH contributed to visualization. AF, IL, CSH contributed to supervision. All authors have read and agreed to the published version of the manuscript.
References
- 1.McCall JE, Cahill TJ. Respiratory care of the burn patient. J Burn Care Rehabil. 2005 May-Jun;26(3):200–6. [PubMed] [Google Scholar]
- 2.Park GY, Park JW, Jeong DH, Jeong SH. Prolonged airway and systemic inflammatory reactions after smoke inhalation. Chest. 2003 Feb;123(2):475–80. doi: 10.1378/chest.123.2.475. [DOI] [PubMed] [Google Scholar]
- 3.Sjoberg F, Elmasry M, Abdelrahman I, Nyberg G, T-Elserafi A, Ursing E, et al. The impact and validity of the Berlin criteria on burn-induced ARDS: Examining mortality rates, and inhalation injury influences. A single center observational cohort study. Burns. 2024 Aug;50(6):1528–1535. doi: 10.1016/j.burns.2024.05.005. [DOI] [PubMed] [Google Scholar]
- 4.Walker PF, Buehner MF, Wood LA, Boyer NL, Driscoll IR, Lundy JB, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care. 2015 Oct 28;19:351. doi: 10.1186/s13054-015-1077-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Committee on Trauma Guidelines for the Operation of Burn Centers. Resources for Optimal Care of the Injured Patient. American College of Surgeons. 2006:79–86. [Google Scholar]
- 6.American Burn Association . Chicago IL: American Burn Association; 2017. 2016 National Burn Repository Report. Available from: https://ameriburn.org/wp-content/uploads/2017/05/2016abanbr_final_42816.pdf. [Google Scholar]
- 7.Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. doi: 10.1186/cc9300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dou Z, Zhang GA. [Systematic review of the epidemiological characteristics of inhalation injury in burn patients in China] Zhonghua Shao Shang Za Zhi. 2021 Jul 20;37(7):654–660. doi: 10.3760/cma.j.cn501120-20200306-00129. Chinese. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dries DJ, Endorf FW. Inhalation injury: epidemiology, pathology, treatment strategies. Scand J Trauma Resusc Emerg Med. 2013 Apr 19;21:31. doi: 10.1186/1757-7241-21-31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Foncerrada G, Culnan DM, Capek KD, González-Trejo S, Cambiaso-Daniel J, Woodson LC, et al. Inhalation Injury in the Burned Patient. Ann Plast Surg. 2018 Mar;80(3) Suppl 2:S98–S105. doi: 10.1097/SAP.0000000000001377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Da Silva E, Vogel U, Hougaard KS, Pérez-Gil J, Zuo YY, Sørli JB. An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function. Curr Res Toxicol. 2021 May 27;2:225–236. doi: 10.1016/j.crtox.2021.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pierrakos C, Karanikolas M, Scolletta S, Karamouzos V, Velissaris D. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012 Feb;4(1):7–16. doi: 10.4021/jocmr761w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012 Aug;122(8):2731–40. doi: 10.1172/JCI60331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H. Acute respiratory distress syndrome: new definition, current and future therapeutic options. J Thorac Dis. 2013 Jun;5(3):326–34. doi: 10.3978/j.issn.2072-1439.2013.04.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Steuer NB, Lüken H, Schlanstein PC, Menne MF, Hoffmann C, Lübke C, et al. Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system. Sci Rep. 2025 Feb 3;15(1):4066. doi: 10.1038/s41598-024-84878-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Enkhbaatar P, Pruitt BA, Jr, Suman O, Mlcak R, Wolf SE, Sakurai H, et al. Pathophysiology, research challenges, and clinical management of smoke inhalation injury. Lancet. 2016 Oct 1;388(10052):1437–1446. doi: 10.1016/S0140-6736(16)31458-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gupta K, Mehrotra M, Kumar P, Gogia AR, Prasad A, Fisher JA. Smoke Inhalation Injury: Etiopathogenesis, Diagnosis, and Management. Indian J Crit Care Med. 2018 Mar;22(3):180–188. doi: 10.4103/ijccm.IJCCM_460_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Woodson LC, Talon M, Traber DL, Herndon DN. Diagnosis and treatment of inhalation injury. In: Herndon DN, editor. Total Burn Care. 5th ed. Amsterdam: Elsevier; 2018. pp. 184e3–194.e3. [Google Scholar]
- 19.Rose JJ, Wang L, Xu Q, McTiernan CF, Shiva S, Tejero J, Gladwin MT. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. Am J Respir Crit Care Med. 2017 Mar 1;195(5):596–606. doi: 10.1164/rccm.201606-1275CI. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Koljonen V, Maisniemi K, Virtanen K, Koivikko M. Multi-detector computed tomography demonstrates smoke inhalation injury at early stage. Emerg Radiol. 2007 Jun;14(2):113–6. doi: 10.1007/s10140-007-0579-z. [DOI] [PubMed] [Google Scholar]
- 21.Cancio LC. Airway management and smoke inhalation injury in the burn patient. Clin Plast Surg. 2009 Oct;36(4):555–67. doi: 10.1016/j.cps.2009.05.013. [DOI] [PubMed] [Google Scholar]
- 22.Hunt JL, Agee RN, Pruitt BA., Jr Fiberoptic bronchoscopy in acute inhalation injury. J Trauma. 1975 Aug;15(8):641–9. doi: 10.1097/00005373-197508000-00004. [DOI] [PubMed] [Google Scholar]
- 23.Marek K, Piotr W, Stanisław S, Stefan G, Justyna G, Mariusz N, et al. Fibreoptic bronchoscopy in routine clinical practice in confirming the diagnosis and treatment of inhalation burns. Burns. 2007 Aug;33(5):554–60. doi: 10.1016/j.burns.2006.08.030. [DOI] [PubMed] [Google Scholar]
- 24.Deutsch CJ, Tan A, Smailes S, Dziewulski P. The diagnosis and management of inhalation injury: An evidence based approach. Burns. 2018 Aug;44(5):1040–1051. doi: 10.1016/j.burns.2017.11.013. [DOI] [PubMed] [Google Scholar]
- 25.Endorf FW, Gamelli RL. Inhalation injury, pulmonary perturbations, and fluid resuscitation. J Burn Care Res. 2007 Jan-Feb;28(1):80–3. doi: 10.1097/BCR.0B013E31802C889F. [DOI] [PubMed] [Google Scholar]
- 26.Albright JM, Davis CS, Bird MD, Ramirez L, Kim H, Burnham EL, et al. The acute pulmonary inflammatory response to the graded severity of smoke inhalation injury. Crit Care Med. 2012 Apr;40(4):1113–21. doi: 10.1097/CCM.0b013e3182374a67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Davis CS, Janus SE, Mosier MJ, Carter SR, Gibbs JT, Ramirez L, et al. Inhalation injury severity and systemic immune perturbations in burned adults. Ann Surg. 2013 Jun;257(6):1137–46. doi: 10.1097/SLA.0b013e318275f424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Romanowski KS, Palmieri TL, Sen S, Greenhalgh DG. More Than One Third of Intubations in Patients Transferred to Burn Centers are Unnecessary: Proposed Guidelines for Appropriate Intubation of the Burn Patient. J Burn Care Res. 2016 Sep-Oct;37(5):e409–14. doi: 10.1097/BCR.0000000000000288. [DOI] [PubMed] [Google Scholar]
- 29.Madnani DD, Steele NP, de Vries E. Factors that predict the need for intubation in patients with smoke inhalation injury. Ear Nose Throat J. 2006 Apr;85(4):278–80. [PubMed] [Google Scholar]
- 30.Desai SR, Zeng D, Chong SJ. Airway management in inhalation injury: a case series. Singapore Med J. 2020 Jan;61(1):46–53. doi: 10.11622/smedj.2019048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ortiz AS, Chan RK, Dion GR. Skin Burns of the Head and Neck. Oper Tech Otolaryngol Head Neck Surg. 2020 Dec;31(4):283–288. doi: 10.1016/j.otot.2020.06.009. [DOI] [Google Scholar]
- 32.Chung KK, Rhie RY, Lundy JB, Cartotto R, Henderson E, Pressman MA, et al. A Survey of Mechanical Ventilator Practices Across Burn Centers in North America. J Burn Care Res. 2016 Mar-Apr;37(2):e131–9. doi: 10.1097/BCR.0000000000000270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.McShane EK, Sun BJ, Maggio PM, Spain DA, Forrester JD. Improving tracheostomy delivery for trauma and surgical critical care patients: timely trach initiative. BMJ Open Qual. 2022 May;11(2):e001589. doi: 10.1136/bmjoq-2021-001589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Morita N, Enkhbaatar P, Maybauer DM, Maybauer MO, Westphal M, Murakami K, et al. Impact of bronchial circulation on bronchial exudates following combined burn and smoke inhalation injury in sheep. Burns. 2011 May;37(3):465–73. doi: 10.1016/j.burns.2010.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Merchant M, Hu SB, Cohen S, Grossman PH, Richards KM, Smith MI. Evaluation of Outcomes following Reduction in Targeted Fluid Administration in Major Burns. Eur Burn J. 2023;4(2):234–247. doi: 10.3390/ebj4020021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Salinas J, Chung KK, Mann EA, Cancio LC, Kramer GC, Serio-Melvin ML, et al. Computerized decision support system improves fluid resuscitation following severe burns: an original study. Crit Care Med. 2011 Sep;39(9):2031–8. doi: 10.1097/CCM.0b013e31821cb790. [DOI] [PubMed] [Google Scholar]
- 37.Carr JA, Phillips BD, Bowling WM. The utility of bronchoscopy after inhalation injury complicated by pneumonia in burn patients: results from the National Burn Repository. J Burn Care Res. 2009 Nov-Dec;30(6):967–74. doi: 10.1097/BCR.0b013e3181bfb77b. [DOI] [PubMed] [Google Scholar]
- 38.Miller AC, Elamin EM, Suffredini AF. Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review. Crit Care Med. 2014 Feb;42(2):413–9. doi: 10.1097/CCM.0b013e3182a645e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Enkhbaatar P, Herndon DN, Traber DL. Use of nebulized heparin in the treatment of smoke inhalation injury. J Burn Care Res. 2009 Jan-Feb;30(1):159–62. doi: 10.1097/BCR.0b013e3181923bd3. [DOI] [PubMed] [Google Scholar]
- 40.Glas GJ, Serpa Neto A, Horn J, Cochran A, Dixon B, Elamin EM, et al. Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis. Ann Intensive Care. 2016 Dec;6(1):33. doi: 10.1186/s13613-016-0138-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kashefi NS, Nathan JI, Dissanaike S. Does a Nebulized Heparin/N-acetylcysteine Protocol Improve Outcomes in Adult Smoke Inhalation? Plast Reconstr Surg Glob Open. 2014 Jul 9;2(6):e165. doi: 10.1097/GOX.0000000000000121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Palmieri TL, Enkhbaatar P, Bayliss R, Traber LD, Cox RA, Hawkins HK, et al. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med. 2006 Jun;34(6):1719–24. doi: 10.1097/01.CCM.0000217215.82821.C5. [DOI] [PubMed] [Google Scholar]
- 43.Foncerrada G, Lima F, Clayton RP, Mlcak RP, Enkhbaatar P, Herndon DN, et al. Safety of Nebulized Epinephrine in Smoke Inhalation Injury. J Burn Care Res. 2017 Nov/Dec;38(6):396–402. doi: 10.1097/BCR.0000000000000575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lopez E, Fujiwara O, Lima-Lopez F, Suman OE, Mlcak RP, Hawkins HK, et al. Nebulized Epinephrine Limits Pulmonary Vascular Hyperpermeability to Water and Protein in Ovine With Burn and Smoke Inhalation Injury. Crit Care Med. 2016 Feb;44(2):e89–96. doi: 10.1097/CCM.0000000000001349. [DOI] [PubMed] [Google Scholar]
- 45.Koga T, Kawazu T, Iwashita K, Yahata R. Pulmonary hyperinflation and respiratory distress following solvent aspiration in a patient with asthma: expectoration of bronchial casts and clinical improvement with high-frequency chest wall oscillation. Respir Care. 2004 Nov;49(11):1335–8. [PubMed] [Google Scholar]
- 46.Mlcak RP, Suman OE, Herndon DN. Respiratory management of inhalation injury. Burns. 2007 Feb;33(1):2–13. doi: 10.1016/j.burns.2006.07.007. [DOI] [PubMed] [Google Scholar]
- 47.Buckley NA, Juurlink DN, Isbister G, Bennett MH, Lavonas EJ. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. 2011 Apr 13;2011(4):CD002041. doi: 10.1002/14651858.CD002041.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Eichhorn L, Thudium M, Jüttner B. The Diagnosis and Treatment of Carbon Monoxide Poisoning. Dtsch Arztebl Int. 2018 Dec 24;115(51-52):863–870. doi: 10.3238/arztebl.2018.0863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Weaver LK. Hyperbaric oxygen therapy for carbon monoxide poisoning. Undersea Hyperb Med. 2014 Jul-Aug;41(4):339–54. [PubMed] [Google Scholar]
- 50.Nguyen L, Afshari A, Kahn SA, McGrane S, Summitt B. Utility and outcomes of hydroxocobalamin use in smoke inhalation patients. Burns. 2017 Feb;43(1):107–113. doi: 10.1016/j.burns.2016.07.028. [DOI] [PubMed] [Google Scholar]
- 51.Costa Santos D, Barros F, Gomes N, Guedes T, Maia M. Face and/or neck burns: a risk factor for respiratory infection? Ann Burns Fire Disasters. 2016 Jun 30;29(2):97–102. [PMC free article] [PubMed] [Google Scholar]
- 52.Liodaki E, Kalousis K, Schopp BE, Mailänder P, Stang F. Prophylactic antibiotic therapy after inhalation injury. Burns. 2014 Dec;40(8):1476–80. doi: 10.1016/j.burns.2014.01.022. [DOI] [PubMed] [Google Scholar]
- 53.Bartley AC, Edgar DW, Wood FM. Pharmaco-management of inhalation injuries for burn survivors. Drug Des Devel Ther. 2009 Feb 6;2:9–16. [PMC free article] [PubMed] [Google Scholar]
- 54.Dyamenahalli K, Garg G, Shupp JW, Kuprys PV, Choudhry MA, Kovacs EJ. Inhalation Injury: Unmet Clinical Needs and Future Research. J Burn Care Res. 2019 Aug 14;40(5):570–584. doi: 10.1093/jbcr/irz055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Walsh DM, McCullough SD, Yourstone S, Jones SW, Cairns BA, Jones CD, et al. Alterations in airway microbiota in patients with PaO2/FiO2 ratio ≤ 300 after burn and inhalation injury. PLoS One. 2017 Mar 30;12(3):e0173848. doi: 10.1371/journal.pone.0173848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, et al. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome. 2016 Feb 11;4:7. doi: 10.1186/s40168-016-0151-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.El-Helbawy RH, Ghareeb FM. Inhalation injury as a prognostic factor for mortality in burn patients. Ann Burns Fire Disasters. 2011 Jun 30;24(2):82–8. [PMC free article] [PubMed] [Google Scholar]
- 58.Puyana S, Ruiz S, Amador F, Mckenney M, Young E, Lim R, et al. The Outcomes of Inhalation Injuries in Lesser Burns: Still a Deadly Injury. Eplasty. 2021 Sep 29;21:e7. [PMC free article] [PubMed] [Google Scholar]
- 59.Niu Z, Ding Z, Chan Y, Yan L, Zhang W, Wang H, et al. Clinical characteristics and predictors of burn complicated with smoke inhalation injury: A retrospective analysis. Exp Ther Med. 2022 Nov 9;24(6):758. doi: 10.3892/etm.2022.11694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.McClintock D, Zhuo H, Wickersham N, Matthay MA, Ware LB. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care. 2008;12(2):R41. doi: 10.1186/cc6846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Kim Y, Kym D, Hur J, Yoon J, Yim H, Cho YS, et al. Does inhalation injury predict mortality in burns patients or require redefinition? PLoS One. 2017 Sep 27;12(9):e0185195. doi: 10.1371/journal.pone.0185195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Klifto KM, Quiroga L, Hultman CS. Substance use and inhalation injury in adult burn patients: retrospective study of the impact on outcomes. Burns Trauma. 2019 Jun 4;7:15. doi: 10.1186/s41038-019-0152-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Watso JC, Romero SA, Moralez G, Huang M, Cramer MN, Jaffery MF, et al. Adults with well-healed burn injuries have lower pulmonary function values decades after injury. Physiol Rep. 2022 May;10(10):e15264. doi: 10.14814/phy2.15264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Won YH, Cho YS, Joo SY, Seo CH. The Effect of a Pulmonary Rehabilitation on Lung Function and Exercise Capacity in Patients with Burn: A Prospective Randomized Single-Blind Study. J Clin Med. 2020 Jul 15;9(7):2250. doi: 10.3390/jcm9072250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Clayton NA, Ward EC, Rumbach AF, Cross RR, Kol MR, Maitz PK. Influence of Inhalation Injury on Incidence, Clinical Profile and Recovery Pattern of Dysphagia Following Burn Injury. Dysphagia. 2020 Dec;35(6):968–977. doi: 10.1007/s00455-020-10098-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Witt CE, Stewart BT, Rivara FP, Mandell SP, Gibran NS, Pham TN, et al. Inpatient and Postdischarge Outcomes Following Inhalation Injury Among Critically Injured Burn Patients. J Burn Care Res. 2021 Nov 24;42(6):1168–1175. doi: 10.1093/jbcr/irab029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Stockly OR, Wolfe AE, Carrougher GJ, Stewart BT, Gibran NS, Wolf SE, et al. Inhalation injury is associated with long-term employment outcomes in the burn population: Findings from a cross-sectional examination of the Burn Model System National Database. PLoS One. 2020 Sep 23;15(9):e0239556. doi: 10.1371/journal.pone.0239556. [DOI] [PMC free article] [PubMed] [Google Scholar]
